Total Payments
$4,437
2024 Payments
$836.60
Companies
31
Transactions
224
Medicare Patients
3,914
Medicare Billing
$538,239
Payment Breakdown by Category
Food & Beverage$4,407 (99.3%)
Education$29.99 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,407 | 223 | 99.3% |
| Education | $29.99 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $818.59 | 58 | $0 (2024) |
| EMD Serono, Inc. | $608.20 | 37 | $0 (2020) |
| Biohaven Pharmaceutical Holding Company Ltd. | $570.51 | 23 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $337.68 | 23 | $0 (2024) |
| Genentech USA, Inc. | $288.80 | 11 | $0 (2024) |
| Allergan, Inc. | $275.73 | 14 | $0 (2020) |
| Validus Pharmaceuticals LLC | $265.72 | 2 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $246.26 | 5 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $118.68 | 6 | $0 (2024) |
| Biogen, Inc. | $113.90 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $836.60 | 32 | Validus Pharmaceuticals LLC ($223.52) |
| 2023 | $1,047 | 57 | AbbVie Inc. ($388.02) |
| 2022 | $919.29 | 41 | Biohaven Pharmaceutical Holding Company Ltd. ($570.51) |
| 2021 | $413.98 | 19 | Biohaven Pharmaceuticals, Inc. ($246.26) |
| 2020 | $239.02 | 15 | Genentech USA, Inc. ($51.39) |
| 2019 | $351.81 | 24 | EMD Serono, Inc. ($186.82) |
| 2018 | $245.45 | 13 | EMD Serono, Inc. ($176.83) |
| 2017 | $384.05 | 23 | EMD Serono, Inc. ($196.71) |
All Payment Transactions
224 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Neurology | ||||||
| 10/17/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Neurology | ||||||
| 09/30/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $32.63 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 07/30/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Neuroscience | ||||||
| 05/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: PAIN | ||||||
| 05/09/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Rare Disease | ||||||
| 05/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/01/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $30.56 | General |
| Category: Central Nervous System | ||||||
| 04/19/2024 | Validus Pharmaceuticals LLC | Equetro (Drug) | Food and Beverage | Cash or cash equivalent | $223.52 | General |
| Category: CNS | ||||||
| 04/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: PAIN | ||||||
| 04/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: PSYCHIATRY | ||||||
| 04/05/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Immunology | ||||||
| 04/04/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.20 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: Immunology | ||||||
| 03/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.16 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Diabetes | ||||||
| 02/29/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $35.65 | General |
| Category: NEUROSCIENCE | ||||||
| 02/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: IMMUNOLOGY | ||||||
| 02/28/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: NEUROLOGY | ||||||
| 02/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/27/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $4.14 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 927 | 1,172 | $310,552 | $122,995 |
| 2022 | 16 | 1,272 | 6,530 | $497,108 | $193,840 |
| 2021 | 12 | 856 | 1,182 | $256,426 | $118,773 |
| 2020 | 11 | 859 | 1,141 | $241,682 | $102,631 |
Total Patients
3,914
Total Services
10,025
Medicare Billing
$538,239
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 339 | 474 | $91,956 | $43,939 | 47.8% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 42 | 43 | $47,300 | $13,934 | 29.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 101 | 173 | $27,450 | $13,690 | 49.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 83 | 95 | $24,890 | $12,323 | 49.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 161 | 186 | $24,552 | $10,826 | 44.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 29 | 29 | $26,535 | $7,667 | 28.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 41 | 41 | $22,714 | $6,236 | 27.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $13,156 | $5,152 | 39.2% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 35 | 35 | $15,995 | $4,233 | 26.5% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 24 | 24 | $8,328 | $2,318 | 27.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $4,524 | $1,584 | 35.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $3,152 | $1,093 | 34.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 354 | 496 | $96,224 | $46,122 | 47.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 186 | 317 | $47,700 | $24,743 | 51.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 11 | 4,900 | $78,400 | $23,431 | 29.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 257 | 334 | $44,088 | $21,823 | 49.5% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 53 | 53 | $57,257 | $17,917 | 31.3% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 74 | 74 | $40,996 | $11,940 | 29.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 64 | 69 | $18,078 | $8,993 | 49.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 25 | 25 | $22,875 | $7,419 | 32.4% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 49 | 49 | $22,393 | $6,528 | 29.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 50 | 50 | $14,950 | $6,435 | 43.0% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 52 | 52 | $18,044 | $5,322 | 29.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 21 | 21 | $7,917 | $3,517 | 44.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 38 | 38 | $7,486 | $2,945 | 39.3% |
About Dr. John Dilullo, MD
Dr. John Dilullo, MD is a Neurology healthcare provider based in Lakeland, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427020460.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Dilullo, MD has received a total of $4,437 in payments from pharmaceutical and medical device companies, with $836.60 received in 2024. These payments were reported across 224 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($4,407).
As a Medicare-enrolled provider, Dilullo has provided services to 3,914 Medicare beneficiaries, totaling 10,025 services with total Medicare billing of $538,239. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Lakeland, FL
- Active Since 02/03/2006
- Last Updated 11/27/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1427020460
Products in Payments
- NURTEC ODT (Drug) $917.29
- Rebif (Biological) $442.80
- UBRELVY (Drug) $391.86
- Equetro (Drug) $265.72
- BOTOX (Biological) $249.50
- Ocrevus (Biological) $237.41
- QULIPTA (Drug) $212.02
- MAYZENT (Drug) $155.61
- KESIMPTA (Drug) $132.44
- VRAYLAR (Drug) $123.06
- ZEPOSIA (Drug) $122.17
- Mavenclad (Biological) $117.56
- NAMZARIC (Drug) $102.80
- REXULTI (Drug) $79.71
- Aimovig (Biological) $72.43
- TYSABRI (Biological) $65.79
- RADICAVA (Drug) $56.69
- Austedo XR (Drug) $54.76
- OCREVUS (Biological) $51.39
- AVONEX (Biological) $48.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Lakeland
Niraja Suresh, M.d, M.D
Neurology — Payments: $94,432
Neurology $94,432
Zuleyma Toledo-Nieves
Neurology — Payments: $83,197
Neurology $83,197
Karla Ledoux, Do, DO
Neurology — Payments: $35,704
Neurology $35,704
Daniel Traviesa, Md, MD
Neurology — Payments: $17,141
Neurology $17,141
Daynet Hisley, Md, MD
Neurology — Payments: $14,647
Neurology $14,647
Dr. Herminio Cuervo-Delgado, M.d, M.D
Neurology — Payments: $8,088
Neurology $8,088